Inhibitory effects of in vivo oxidized high‐density lipoproteins on platelet aggregation: evidence from patients with abetalipoproteinemia-Reference-Cited by-同舟云学术

Inhibitory effects of in vivo oxidized high‐density lipoproteins on platelet aggregation: evidence from patients with abetalipoproteinemia

Published:2013-03-18 Issue:7 Volume:27 Page:2855-2861
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Calzada Catherine¹,Véricel Evelyne¹,Colas Romain¹,Guillot Nicolas¹,El Khoury Graziella¹,Drai Jocelyne¹,Sassolas Agnès¹,Peretti Noël¹²,Ponsin Gabriel¹,Lagarde Michel¹,Moulin Philippe¹³

Affiliation:

1. Université de LyonInstitut National de la Santé et de la Recherche Médicale (INSERM)Unité Mixte de Recherche (UMR) 1060Cardiovasculaire, Métabolisme, Diabétologie, et Nutrition (CarMeN) LaboratoryUniversité Lyon 1Institut National des Sciences Appliquées de Lyon (INSA‐Lyon)Institut Multidisciplinaire de Biochimie des Lipides (IMBL)VilleurbanneFrance

2. Service de Nutrition et Gastroentérologie, Hospices Civils de LyonLyon BronFrance

3. Fédération d'Endocrinologie, Hospices Civils de LyonLyon BronFrance

Funder

Centre National de la Recherche Scientifique

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.12-225169

Reference33 articles.

1. The metabolism and anti-atherogenic properties of HDL